Robert G.Marshall II (Rob)

Partner

London + 44.20.7039.5304

With 20 years of experience, Rob Marshall advises public and private companies on executive compensation and equity plan issues on a global basis. He has extensive experience regarding international executive compensation arrangements, cross-border transactions, and HR and employment/severance matters and has implemented executive compensation programs in more than 100 countries. He regularly counsels clients on securities compliance and disclosure, tax, corporate governance, and stock exchange issues applicable to executive compensation and equity programs. Rob also assists with the design and implementation of stock- and cash-based plans, as well as a variety of other arrangements.

Rob is a member of the State Bar of California and the National Association of Stock Plan Professionals. He is recommended in The Legal 500 US for employee benefits and executive compensation and has been named one of the Bay Area's "best lawyers" by Bay Area Lawyer Magazine. In addition, he has served as a guest speaker at executive and equity compensation conferences.

Experience

  • JTC acquires NES Financial for up to $116 millionJones Day advised JTC PLC in the acquisition of NES Financial, a technology-enabled provider of specialist fund administration and treasury services recognized on the San Francisco Business Times top Bay Area fintech list, for up to $116 million.
  • Partech Partners invests in TradeDepotJones Day represented Partech Partners in connection with its purchase of Series A Convertible Preferred Stock in a private placement by TradeDepot, the innovative SaaS platform for FMCG distribution in Africa.
  • Lam Research attempts merger with KLA-TencorJones Day represented Lam Research Corporation in its proposed acquisition of all outstanding shares of KLA-Tencor Corporation in a cash and stock transaction that placed an equity value on KLA-Tencor of approximately $10.6 billion based on its closing stock price on October 20, 2015.
  • Sycamore Hill Capital completes sale of Illume to Regent Holding Co.Jones Day represented Sycamore Hill Capital Group in connection with its sale of Illume, a distributor of home fragrance and beauty products, to Regent Holding Co.
  • Cellectis completes $228 million IPOJones Day represented Cellectis SA, a French biotechnology company that develops novel cancer treatments, in connection with its $228 million initial public offering in the United States and Nasdaq listing.
  • Monolithic Power Systems acquires Sensima TechnologyJones Day advised Monolithic Power Systems, Inc. in the acquisition of Sensima Technology SA, a developer of magnetic sensor technologies for angle measurements as well as three-dimensional magnetic field sensing.
  • Multinational corporation conducts internal investigation of Brazil operationJones Day conducted a targeted investigation of alleged misconduct and potential violations of the Foreign Corrupt Practices Act in a multinational corporation’s Brazilian operation.
  • Lam Research acquires semiconductor equipment maker Novellus Systems in $3.3 billion all-stock transactionJones Day advised Lam Research Corp. in its $3.3 billion stock-for-stock acquisition of Novellus Systems, Inc.
  • SunPower and Total partner to create new global leader in solar industry with $1.4 billion tender offerJones Day advised SunPower Corporation in the completion of the $1.4 billion tender offer by Total for up to 60% of SunPower's outstanding Class A Common Shares and 60% of SunPower's outstanding Class B Common Shares at a price of $23.25/share for each class.
  • Quantal International acquires Bullrun FinancialJones Day advised Quantal International, Inc. in its acquisition of Bullrun Financial, Inc.
  • Speaking Engagements

    • September 24-25, 2015
      Compensation Design Trends -- Public and Private Companies, Jones Day's 2015 Critical Updates in Executive Compensation and Benefits Symposium
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.